Literature DB >> 21554911

Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients.

Suleyman Aydin1, Ersel Dag, Yusuf Ozkan, Ozgur Arslan, Guray Koc, Semai Bek, Serkan Kirbas, Tayfun Kasikci, Dilek Abasli, Zeki Gokcil, Zeki Odabasi, Zekiye Catak.   

Abstract

A relationship between hormones and seizures has been reported in animals and humans. Therefore, the purpose of this study was to investigate the association between serum levels of prolactin, nesfatin-1 and ghrelin measured different times after a seizure or non-epileptic event and compared with controls. The study included a total of 70 subjects, and of whom 18 patients had secondary generalized epilepsy (SGE), 16 patients had primary generalized epilepsy (PGE), 16 patients exhibited paroxysmal event (psychogenic) and 20 healthy males were control subjects. The first sample was taken within 5min of a seizure, with further samples taken after 1, 24, and 48h so long as the patient did not exhibit further clinically observable seizures; blood samples were taken once from control subjects. Prolactin was measured immediately using TOSOH Bioscience hormone assays. Nesfatin-1 and ghrelin peptides were measured using a commercial immunoassay kit. Patients suffering from focal epilepsy with secondary generalization and primary generalized epilepsy presented with significantly higher levels of serum prolactin and nesfatin-1 and lower ghrelin levels 5min, 1 and 24h after a seizure than patients presenting with paroxysmal events (psychogenic) and control subjects; the data were similar but not statistically significant after 48h. The present study suggests that increased serum prolactin and nesfatin-1 concentrations, decreased ghrelin concentrations could be used as markers to identify patients that have suffered a recent epileptic seizure or other paroxysmal event (psychogenic).
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554911     DOI: 10.1016/j.peptides.2011.04.021

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  18 in total

Review 1.  Metabolic hormones in saliva: origins and functions.

Authors:  S Zolotukhin
Journal:  Oral Dis       Date:  2012-09-21       Impact factor: 3.511

Review 2.  Nesfatin-1 and its effects on different systems.

Authors:  C Ayada; Ü Toru; Y Korkut
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

3.  Other Possible Methods in the Differential Diagnosis of Epileptic and Non-Epileptic Seizures.

Authors:  Mehmet Yücel; Hakan Akgün; Oğuzhan Öz; Şeref Demirkaya
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

4.  The discriminative value of blood gas analysis parameters in the differential diagnosis of transient disorders of consciousness.

Authors:  Karmele Olaciregui Dague; R Surges; J Litmathe; L Villa; J Brokmann; J B Schulz; M Dafotakis; O Matz
Journal:  J Neurol       Date:  2018-07-09       Impact factor: 4.849

5.  Autonomic, Endocrine, and Inflammation Profiles in Functional Neurological Disorder: A Systematic Review and Meta-Analysis.

Authors:  Sara Paredes-Echeverri; Julie Maggio; Indrit Bègue; Susannah Pick; Timothy R Nicholson; David L Perez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2021-10-29       Impact factor: 2.198

Review 6.  Multi-functional peptide hormone NUCB2/nesfatin-1.

Authors:  Suleyman Aydin
Journal:  Endocrine       Date:  2013-03-23       Impact factor: 3.633

7.  Inactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents.

Authors:  Jeanelle Portelli; Leen Thielemans; Luc Ver Donck; Ellen Loyens; Jessica Coppens; Najat Aourz; Jeroen Aerssens; Katia Vermoesen; Ralph Clinckers; Anneleen Schallier; Yvette Michotte; Dieder Moechars; Graham L Collingridge; Zuner A Bortolotto; Ilse Smolders
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

8.  The role of diminishing appetite and serum nesfatin-1 level in patients with burn wound infection.

Authors:  Ayse Albayrak; Ismail Demiryilmaz; Yavuz Albayrak; Belkiz Aylu; Bunyami Ozogul; Serkan Cerrah; Muhammed Celik
Journal:  Iran Red Crescent Med J       Date:  2013-05-05       Impact factor: 0.611

Review 9.  Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.

Authors:  Carmela Giordano; Maddalena Marchiò; Elena Timofeeva; Giuseppe Biagini
Journal:  Front Neurol       Date:  2014-04-29       Impact factor: 4.003

Review 10.  Neuropeptides as targets for the development of anticonvulsant drugs.

Authors:  Elke Clynen; Ann Swijsen; Marjolein Raijmakers; Govert Hoogland; Jean-Michel Rigo
Journal:  Mol Neurobiol       Date:  2014-04-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.